European Acqusition Powers Cannabis Company Organigram to Record Revenues
The acquisition added about $38 million in net revenue and helped Organigram post $105.8 million in quarterly net revenue and a return to profit.
- Organigram Global Inc. reported record third-quarter fiscal 2026 results Tuesday, with net revenue surging to $105.8 million, driven largely by the acquisition of German-based Sanity Group GmbH.
- The April acquisition of Sanity added about $38 million in net revenue during the quarter. Yamanaka stated the company is now a fundamentally different entity with broader geographic reach and increased scale.
- In Canada, Organigram holds an 11.1 per cent share of the recreational cannabis market, including 12.5 per cent of the cannabis flower category and 36 per cent of regular pre-rolls.
- Net income reached $105.5 million, marking a turnaround from the $6.3 million loss in the third quarter of 2025, while diluted earnings per share rose to about $0.77.
- Expanding its reach, the company is targeting growth in Switzerland, Poland, the U.K., and Czechia while reducing its product portfolio by about 10 per cent to focus on fewer, stronger brands.
14 Articles
14 Articles
European acquisition powers cannabis company Organigram to record revenues
TORONTO — Cannabis company Organigram Global Inc. says the acquisition of a European medical cannabis company has helped drive it to record quarterly revenues and fundamentally reshaped the firm.
The cannabis company Organigram Global claims that the acquisition of a European medical cannabis company allowed it to record a record quarterly turnover.
European acqusition powers cannabis company Organigram to record revenues
TORONTO - Cannabis company Organigram Global Inc. says the acquisition of a European medical cannabis company has helped drive it to record quarterly revenues.
Organigram Reports Record Third Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Aug 11, 2026-
Coverage Details
Bias Distribution
- 45% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










